Anti-tumor activity of elacestrant (RAD1901) in combination with alpelisib (BYL-719) in patient-derived xenograft models of ER plus breast cancer-MedSci.cn

Anti-tumor activity of elacestrant (RAD1901) in combination with alpelisib (BYL-719) in patient-derived xenograft models of ER plus breast cancer

Sankaran, B; Garner, F; Hattersley, G; Purandare, D; Bihani, T

CANCER RESEARCH, 2018; 78 (4):

科室
- - 订阅+
  - 更多科室
工具
服务